Enzyme
Enzyme inhibitors are molecules that bind to enzymes and decrease their activity. These inhibitors are widely used in research to study enzyme kinetics, regulation, and the role of specific enzymes in metabolic pathways. Enzyme inhibitors are also crucial in drug development, as many therapeutic agents function by inhibiting enzymes involved in disease processes. By targeting enzymes, these inhibitors can modulate biochemical pathways and offer potential treatments for various diseases. At CymitQuimica, we provide a comprehensive selection of high-quality enzyme inhibitors to support your research in biochemistry, pharmacology, and drug discovery.
Subcategories of "Enzyme"
- Carbonic Anhydrase(196 products)
- Hydroxylase(36 products)
- MPO(2 products)
- Reductase(51 products)
- Tyrosinase(71 products)
Found 3619 products of "Enzyme"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Carbonic anhydrase inhibitor 21
Compound 5h, known as Carbonic anhydrase inhibitor 21, is a specific inhibitor of carbonic anhydrase (hCA IX) with a K\(_i\) of 15.1 nM, demonstrating high selectivity compared to other isoforms studied. This compound is utilized in anticancer research.Formula:C32H48N4O10P2S2Molecular weight:774.228715,6-Dihydro-2H-pyran-2-one
CAS:5,6-Dihydro-2H-pyran-2-one is a carbonic anhydrase 1/9 inhibitor that inhibits KB cell viability.Formula:C5H6O2Color and Shape:SolidMolecular weight:98.1TPH1-IN-1
TPH1-IN-1 (compound 40) is a xanthine derivative that serves as an inhibitor of tryptophan hydroxylase TPH1, with an IC50 of 110.1 nM.Formula:C21H18N6O4SColor and Shape:SolidMolecular weight:450.47CAIX/CAXII-IN-4
CAIX/CAXII-IN-4 (Compound 7h) is an inhibitor of carbonic anhydrase (CA) that binds to CAIX, CA XII, and CAII with Ki values of 1.324 μM, 0.435 μM, and 3.035 μM, respectively. This compound exhibits broad-spectrum anti-tumor activity and inhibits the proliferation of central nervous system tumor cells U251, with a GI50 of 0.361 μM.Formula:C23H21N5O3SColor and Shape:SolidMolecular weight:447.51hCAIX-IN-19
hCAIX-IN-19 is a sulfonamide inhibitor with an inhibition constant (KI) of 6.2 nM for hCAIX, exhibiting significant selectivity towards hCAIX over hCAI (hCA I/Color and Shape:Odour SolidhCA/VEGFR-2-IN-4
hCA/VEGFR-2-IN-4 (compound 15b), an indolinylbenzenesulfonamide, serves as a potential dual inhibitor targeting cancer-related human carbonic anhydrases hCA IX/Formula:C22H23FN6O5SPurity:98%Color and Shape:SolidMolecular weight:502.52hCAII-IN-6
"hCAII-IN-6 (S-13) inhibits hCA II (4.4 nM) and isoforms I, IV, IX (9.2, 480.2, 14.7 nM). For glaucoma research."Formula:C20H25N3O4SColor and Shape:SolidMolecular weight:403.5β-Amylase, from soy
CAS:Purity:≥ 10.0units/mgColor and Shape:White to off-white powderMolecular weight:-Peroxidase
CAS:Purity:≥ 85units/mg (dry basis)Color and Shape:Beige to light-brown, reddish brown or dark brown lyophilised powderMolecular weight:-hCA/VEGFR-2-IN-2
Compound 8g (hCA/VEGFR-2-IN-2) is an indolinonylbenzenesulfonamide identified as a potential dual inhibitor targeting cancer-associated isozymes hCA IX/XII andFormula:C23H26N6O5SPurity:98%Color and Shape:SolidMolecular weight:498.55Carbonic anhydrase inhibitor 29
Carbonic anhydrase inhibitor29 (Compound 5d) is an inhibitor targeting carbonic anhydrase IX and XII, with an inhibition constant (Ki) of 26.6 nM for carbonic anhydrase IX and a Ki of 10.9 nM for carbonic anhydrase XII. Carbonic anhydrase inhibitor29 can be used in cancer research.Color and Shape:Odour Solid
